Mondaq Canada: Intellectual Property
Torys LLP
On November 9, the Federal Court issued its ruling on the judicial review of a decision by the Patented Medicine Prices Review Board (PMPRB) regarding the drug product Differin ...
Bereskin & Parr LLP
Revised Chapter 17 of the Manuel of Patent Office Practice (MOPOP) released on November 10, 2017 includes a number of new sections including commentary on "Kits and packages" ...
Bereskin & Parr LLP
Canada provides both a statutory and common law exemption to patent infringement.
Norton Rose Fulbright Canada LLP
Trademark owners are increasingly using an abbreviated process – the application – to enforce their rights. Applications avoid the costs and delay of discovery and the complexities of trial.
Bereskin & Parr LLP
We reviewed innovator drugs approved by Health Canada in 2015-2016 and found that there was no clear winner between the legal protections offered by Canadian patents and data protection.
Bereskin & Parr LLP
Canadian patents have recently received a boost from the federal government and courts. Our top court recently removed the promise doctrine from patent utility law as a basis to challenge patents.
Bereskin & Parr LLP
The draft Patent Rules address a number of technical aspects pertaining to divisional application practice.
Sim, Lowman, Ashton & McKay LLP
Canada is currently in the process of modernizing and harmonizing its intellectual property laws to comply with a number of international treaties.
Bennett Jones LLP
Two recent copyright infringement disputes involved the rare intersection of intellectual property with real property.
McMillan LLP
As previously reported in our bulletin, Bill C-45, an Act respecting cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts...
Goldman Sloan Nash & Haber LLP
When a brand name is used internationally additional issues can arise.
Bennett Jones LLP
Courts in Canada are presumed to be open and accessible to the public.
Gowling WLG
On September 27, 2017, a two-member Hearing Panel of the Patented Medicine Price Review Board (PMPRB) ruled that the ultra-rare disease drug Soliris® (eculizumab), manufactured by Alexion Pharmaceuticals Inc. (Alexion), was "excessively priced." The Panel ordered both a reduction of the price of Soliris going forward and required Alexion to pay past "excessive" revenues.
Bereskin & Parr LLP
The Canadian Intellectual Property Office (CIPO), an agency of Innovation, Science and Economic Development Canada, this week released a report entitled Patented Inventions in CCMTs.
Norton Rose Fulbright Canada LLP
In anticipation of the upcoming changes to the Trade-marks Act (the "Act"), now scheduled to take place in 2019, the Canadian Intellectual Property Office ("CIPO") is inviting owners of registered trademarks that are due for renewals as of January 2018 to voluntarily categorize the goods and services covered by their registration based on the Nice Classification prior to or upon renewal.
Bennett Jones LLP
The cost of litigation can be a non-starter for an intellectual property owner with a strong infringement case.
Goldman Sloan Nash & Haber LLP
An industrial design registration can protect the ornamental or aesthetic aspect of a product.
Bereskin & Parr LLP
As we previously reported on August 3, 2017, the Canadian Intellectual Property Office (CIPO) has recently published proposed new amendments to the Patent Rules.
Bereskin & Parr LLP
Many international R&D collaborations involve trade secrets. If there is a disagreement arising from potential trade secret disclosure or misappropriation, then enforcement of trade secret rights...
McMillan LLP
The PPH pilot project between CIPO and SIPO has a current sunset date of August 31, 2018.
Latest Video
Most Popular Recent Articles
McMillan LLP
As any startup company that has built a consumer facing brand will tell you, there are countless names to secure, from choosing a corporate name and registering a trademark...
Blake, Cassels & Graydon LLP
Entrepreneurs and investors are quickly seeking to capitalize on what has been coined the "Green Rush" to the cannabis market.
Gowling WLG
This webinar considers free trade zones in Singapore, China and the UAE and in particular; their impact on counterfeit and pirate goods; the challenges and benefits that they present to brand owners...
McInnes Cooper
Intellectual Property (IP) can be a valuable asset – even the most valuable asset – of a business.
Norton Rose Fulbright Canada LLP
La Cour fédérale a récemment accueilli l'appel de Les Marques Métro / Metro Brands S.E.N.C. (Metro) de la décision de la Commission des oppositions datée du 22 décembre 2015.
Norton Rose Fulbright Canada LLP
Intellectual property often forms an important part of a target's assets, especially for start-ups and high-tech companies. It is important for both the purchaser and the vendor to understand the....
Borden Ladner Gervais LLP
As of September 21, 2017, Canada has implemented a number of amendments to the Canadian Trade-marks Act related to the protection of geographical indications ("GIs").
Norton Rose Fulbright Canada LLP
These amendments stem from the Comprehensive Economic and Trade Agreement (CETA) between Canada and the EU.
Borden Ladner Gervais LLP
The Federal Court recently issued the public decision in the reference on the patent infringement finding and the section 8 damages finding between AstraZeneca and Apotex.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with